TYK2 inhibition: changing the treatment landscape for psoriasis?
Sign Up to like & getrecommendations! Published in 2021 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2022.2008240
Abstract: Psoriasis is a common immune-mediated inflammatory disease affecting approximately 2% of individuals living in Western countries. Patients with psoriasis suffer from a multitude of comorbidities such as psoriatic arthritis, inflammatory bowel disease, anxiety and depression,… read more here.
Keywords: tyk2; psoriasis; deucravacitinib; poetyk pso ... See more keywords
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary.
Sign Up to like & getrecommendations! Published in 2023 at "Immunotherapy"
DOI: 10.2217/imt-2023-0061
Abstract: WHAT IS THIS SUMMARY ABOUT? This is a summary of a paper published in a medical journal that describes the results of a study called POETYK PSO-1, which looked at a new treatment called deucravacitinib… read more here.
Keywords: poetyk pso; plaque psoriasis; treatment; psoriasis ... See more keywords
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
Sign Up to like & getrecommendations! Published in 2023 at "Immunotherapy"
DOI: 10.2217/imt-2023-0062
Abstract: WHAT IS THIS SUMMARY ABOUT? This is a summary of a paper published in a medical journal that describes the results of a study called POETYK PSO-2, which investigated a new treatment for plaque psoriasis.… read more here.
Keywords: deucravacitinib; poetyk pso; plaque psoriasis; treatment ... See more keywords